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Neurogenesisences cell proliferation, death and differentiation during development of the
central nervous system (CNS). Hormone action is mediated by T3 receptors (TR) of which there are two
subtypes, TRα and TRβ. Speciﬁc roles for TR subtypes in CNS development are poorly understood. We
analyzed involvement of TRα and TRβ in neural cell proliferation during metamorphosis of Xenopus laevis.
Cell proliferation in the ventricular/subventricular neurogenic zones of the tadpole brain increased
dramatically during metamorphosis. This increase was dependent on T3 until mid-prometamorphosis, after
which cell proliferation decreased and became refractory to T3. Using double labeling ﬂuorescent
histochemistry with confocal microscopy we found TRα expressed throughout the tadpole brain, with
strongest expression in proliferating cells. By contrast, TRβ was expressed predominantly outside of
neurogenic zones. To corroborate the histochemical results we transfected living tadpole brain with a Xe-
nopus TRβ promoter-EGFP plasmid and found that most EGFP expressing cells were not dividing. Lastly,
treatment with the TRα selective agonist CO23 increased brain cell proliferation; whereas, treatment with
the TRβ-selective agonists GC1 or GC24 did not. Our ﬁndings support the view that T3 acts to induce cell
proliferation in the tadpole brain predominantly, if not exclusively, via TRα.
© 2008 Elsevier Inc. All rights reserved.IntroductionThyroid hormone (T3) plays a critical role in postembryonic
maturation of the vertebrate brain. In mammals, T3 has been shown
to inﬂuence dendritic branching, axonal density, synapse number,
myelination, and cell proliferation (Oppenheimer and Schwartz, 1997;
Porterﬁeld and Hendrich, 1993). The lack of TH during fetal and
neonatal life results in a condition of severe mental retardation known
as cretinism (Legrand, 1982; Porterﬁeld and Hendrich, 1993). Disrup-
tion of T3 signaling in the fetus or neonate by environmental chemicals
can result in impaired neurological development (Porterﬁeld, 1994;
Zoeller, 2005).
Thyroid hormone acts by binding to ligand-activated transcription
factors (thyroid hormone receptors; TR) and regulating gene tran-
scription (Nunez et al., 2008). In all jawed vertebrates that have been
studied there are two paralogous genes that code for TRs, designated
TRα and TRβ (reviewed by Furlow and Neff, 2006). In mammals,Cellular and Developmental
ichigan, Ann Arbor, MI 48109-
l rights reserved.several functional TR isoforms resulting from differential mRNA
processing have been identiﬁed (TRα1, TRβ1, TRβ2, TRβ3). The TRα2
isoform does not bind ligand, may function as a dominant negative
transcriptional repressor, and is highly expressed throughout the
developing rodent brain (Bradley et al., 1992). The cell type and
developmental stage-speciﬁc expression of TR genes suggest that the
protein products subserve different functions in brain development
(Nunez et al., 2008).
The amphibian tadpole is an important model system for
investigating the molecular basis for T3 action in development.
Thyroid hormone is required for tadpole metamorphosis, during
which time the brain undergoes morphological and biochemical
changes that prepare the animal for adult life (Denver, 1998).
Metamorphosis often involves a habitat shift from an aquatic to a
terrestrial environment, and the adult frog exhibits dramatically
different behaviors and other life history characteristics compared
with the tadpole (Denver et al., 2002). This process requires the
creation, modiﬁcation or elimination of many structures. For example,
the Mauthner neurons found on either side of the medulla and the
sensory and motoneurons supplying the tail are lost (reviewed by
Denver, 1998). Conversely, new structures such as themajor portion of
the retina arises, along with associated ipsilateral visual projections in
the diencephalon and mesencephalon (Hoskins, 1990). The
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the diencephalon and their projections to the median eminence
develop. Thyroid hormone is critical for all of these changes
(reviewed by Denver, 1998). Earlier studies using classical histo-
chemical staining showed that thyroid hormone treatment increased
apparent mitotic activity in different regions of the central nervous
system (CNS) of several amphibian species (Chibon and Dournon,
1974; Weiss and Rossetti, 1951a; Weiss and Rossetti, 1951b). Each of
these studies focused on speciﬁc brain regions, and there has not
been a systematic analysis of developmental changes or effects of
exogenous T3 on cell proliferation throughout the CNS of an
amphibian during metamorphosis.
Xenopus laevis has four TR genes, two TRα and two TRβ
(designated A or B) owing to its pseudotetraploidy (Yaoita et al.,
1990). In tadpoles the TRα is expressed shortly after hatching and
remains at a relatively constant level throughout tadpole develop-
ment and metamorphosis, increasing slightly during late prometa-
morphosis (Kawahara et al., 1991; Yaoita and Brown, 1990). By
contrast, the TRβ is expressed at a very low level in the tadpole but
increases dramatically during prometamorphosis coincident with
rising plasma T3 concentrations. Several lines of evidence support a
role for TRα in establishing tissue competence to respond to T3, and
in the proliferative actions of the hormone, particularly in the
hindlimbs. Whereas, the expression pattern of TRβ, which is
dependent on the rise in plasma T3 during metamorphosis, and
ﬁndings using the TRβ speciﬁc T3 analog GC1 support the view that
TRβ functions in cell differentiation and apoptosis (reviewed by
Furlow and Neff, 2006).
In the present study we analyzed cell proliferation in the tadpole
CNS and the involvement of speciﬁc TR subtypes in this process. We
determined the developmental schedule and thyroid dependence of
cell proliferation in ventricular/subventricular neurogenic zones (VZ/
SVZ) throughout the tadpole brain during metamorphosis. We used
histochemistry to localize TRα and TRβ expression, and proliferating
cells in the tadpole brain. Using electroporation-mediated gene
transfer into the brain of living tadpoles, we asked whether the TRβ
gene promoter is activated in proliferating cells. Lastly, we treated
tadpoles with TR subtype-speciﬁc agonists and analyzed brain cell
proliferation to determine which TR subtype mediates the neurogenic
actions of T3 during metamorphosis of X. laevis.
Materials and methods
Animals and animal husbandry
Xenopus laevis tadpoles (obtained from Xenopus One, Dexter, MI)
were raised in dechlorinated tap water (water temperature, 21–
22 °C) and fed pulverized rabbit chow ad libitum. Developmental
stages were assigned according to Nieuwkoop and Faber (1994) and
general staging criteria of Etkin (1968) where premetamorphosis is
the stage of tadpole development when the animal grows but little or
no morphological change occurs and plasma thyroid hormone
concentrations are low; prometamorphosis is the stage when
metamorphosis begins, hindlimb growth accelerates and the thyroid
gland becomes active and secretes thyroid hormone in response to
increasing plasma concentrations of pituitary thyroid stimulating
hormone; and metamorphic climax is the ﬁnal and most rapid phase
of morphological change when thyroid activity is at its peak. Thyroid
hormone (3,5,3′-L-triiodothyronine; T3 sodium salt; ﬁnal concentra-
tion 10 or 50 nM; Sigma-Aldrich, St. Louis, MO) or bromodeoxyur-
idine (BrdU; ﬁnal concentration 500 μM Sigma-Aldrich) were added
to the aquarium water, and the water was changed and hormone
replenished daily over the treatment period (3–48 h; see below). The
goitrogen methimazole (MMI; Sigma-Aldrich) was added to the
aquarium water to a ﬁnal concentration of 1 mM and treatment
continued for 7 days (see Denver et al., 1997). At the termination ofeach experiment tadpoles were euthanized by immersion in 0.1%
benzocaine and brains harvested for histochemistry.
Experimental design for cell proliferation studies
The experimental paradigms for BrdU labeling and T3 treatment
are depicted graphically in Fig. 1.
Experiment 1
We ﬁrst analyzed the effect of T3 on cell proliferation throughout the
brain of premetamorphic X. laevis tadpoles (NF stage 52). Tadpoleswere
immersed in BrdUwith orwithout T3 (50 nM) for 48 h (n=5/treatment).
We sectioned brains sagittally and analyzed BrdU incorporation by
immunohistochemistry (IHC; see below).
Experiment 2
We next conducted an experiment to determine whether T3
treatment 1) caused a shortening of the cell cycle time, or 2) recruited
stem cells that were not dividing to enter mitosis. The experiment
involved a ‘pulse–chase’ design. Early prometamorphic tadpoles (NF
stage 54) were immersed in BrdU for 7 h (‘pulse’). They were then
transferred to fresh water without BrdU for 24 h (‘chase’; to clear
the BrdU), then treated with or without T3 (50 nM) for 24 or 48 h
(n=6–12/treatment).
Experiment 3
We examined developmental stage-dependent changes in brain
cell proliferation in tadpoles undergoing spontaneous metamorpho-
sis, and we determined if the effects of T3 on cell proliferation are
stage-dependent. Tadpoles at different developmental stages (NF 52–
53, 54–55, 56–57, 58–59, 60–61, or 62–63) were treated with or
without T3 (50 nM) for 48 h followed by immersion in BrdU (T3 still
present) for 3 h before sacriﬁce (n=6–12/group). Brains were collected
and processed for ﬂuorescent IHC for BrdU, in situ hybridization
histochemistry (ISHH) for TRα or TRβmRNAs, dual ﬂuorescent IHC for
BrdU and ISHH for TRα mRNA, or dual ﬂuorescent IHC for BrdU and
TRβ protein (described below).
Experiment 4
We tested whether the increase in endogenous thyroid hormone
during metamorphosis accounts for the increase in brain cell
proliferation by blocking thyroid hormone synthesis with MMI.
Prometamorphic tadpoles (NF stage 56) were chosen for this study
since thyroid hormone synthesis and secretion rises at this stage of
development (Krain and Denver, 2004; Leloup and Buscaglia, 1977;
Tata, 1993) and there is a high rate of cell proliferation throughout
the brain (see Results). Tadpoles were treated with or without 1 mM
MMI for 5 days. The MMI-treated group was then divided into two
groups, one with and one without T3 (10 nM) and the treatments
were continued for 2 more days. Thus, there were three treatment
groups at the end of the experiment: vehicle-treated controls, MMI,
and MMI+T3. Brains (n=5/treatment) were collected and processed
for IHC for BrdU or phosphorylated histone 3 (pH3; see below).
Experimental design for thyroid hormone analog experiments
We used three different thyroid hormone analogs that are
selective agonists for TRα or TRβ to test for effects on tadpole
brain cell proliferation. GC1 and GC24 are selective agonists for TRβ.
GC1 binds to TRβ with an afﬁnity 5–7 times greater than for TRα, but
shows 10–100-fold greater selectivity for TRβ vs. TRα in transfection
assays (Chiellini et al., 1998; Furlow et al., 2004). GC24 is more
speciﬁc, exhibiting 40–60 greater selectivity for TRβ than GC1
(Borngraeber et al., 2003). Both GC1 and GC24 exhibit afﬁnities for
TRβ in binding assays, or potencies in transfection assays that are
comparable to or greater than those observed for the native ligand T3
Fig. 1. Schematic representations of tadpole treatment paradigms. Hormones or drugs were added to the aquarium water at the indicated times. Experiment 1. Premetamorphic
tadpoles (NF stage 52) were treated+/−T3 plus BrdU (500 μM) for 48 h before sacriﬁce. Experiment 2. Early prometamorphic tadpoles (NF stage 54) were immersed in BrdU for 7 h
then treated+/−T3 for 24 or 48 h (in the absence of BrdU). Experiment 3. Tadpoles at different developmental stages were treated+/−T3 for 48 h and pulsed with BrdU for the ﬁnal 3 h
to label mitotic cells. Experiment 4. Prometamorphic tadpoles (NF stage 56) were treated with the goitrogen methimazole (MMI; 1 mM) for 1 week before sacriﬁce. A subset of MMI-
treated tadpoles received T3 for the ﬁnal 2 days. Arrows indicate time of sacriﬁce.
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CO23 is a TRα selective agonist which, although it has similar afﬁnity
for TRα and TRβ when tested in in vitro binding assays, shows 5–10
times greater potency in cell-based transactivation assays for TRα
compared with TRβ (Ocasio and Scanlan, 2006). In these assays CO23
exhibited approximately 10 times lower potency than T3. The TRα
selectivity of CO23 is further supported by its activity in the Xenopus
tadpole metamorphosis assay, where it caused signiﬁcant growth of
the hindlimbs, considered to be a TRα-dependent process, but was
much less potent in causing tail or gill resorption, or cranial
restructuring, two processes thought to be dependent on TRβ (Ocasio
and Scanlan, 2006). We dissolved the T3 and the analogs in
dimethylsulfoxide (DMSO); controls were treated with DMSO only,
and all treatments received DMSO to a ﬁnal concentration of 0.001%
in the aquarium water. We added the compounds directly to the
aquarium water and changed the water and replenished the
compounds at 24 h.
We treated premetamorphic tadpoles (NF stage 52) with vehicle,
T3, GC1, GC24 or CO23 for 48 h before sacriﬁce and IHC analysis for
pH3 in the brain (n=4/treatment). The compounds were added to the
aquarium water to a ﬁnal concentration of 10 nM for T3, and 100 nM
for the thyroid hormone analogs. We continued treating six animals in
each group for an additional 4 days to assess effects on external
metamorphic changes. The T3 treated animals showed dramatic
metamorphic changes by 3 days and all died by day 4 of treatment.
The goal was to verify the bioactivity of the GC compounds by
following external morphological changes; Furlow et al. (2004)
showed that doses of GC1 at 50 nM or above caused gill and tail
resorption, but had little or no effect on limb growth except at the
highest concentration tested (N200 nM).Thyroid hormone receptor riboprobes and TR antisera
We made subtype-speciﬁc riboprobes for X. laevis TRs by
generating partial cDNAs by PCR. PCR fragments of TRα (spanning
amino acids 122–384) and TRβ (spanning amino acids 245–521) were
subcloned into the pGEM-T easy vector following the manufacturer's
instructions (Promega). The orientation and sequence of the cloned
products were veriﬁed by direct DNA sequencing. Linearized plasmids
were used for riboprobe synthesis (see below).
We used a rabbit anti-X. laevis TRα (xTRα) polyclonal serum (gift
of Yun-Bo Shi; #94114) that was raised against two synthetic peptides
corresponding to amino acids 1–18 and 15–34 of the xTRα protein
coupled to keyhole limpet hemocyanin. A rabbit anti-X. laevis TRβ
(xTRβ) polyclonal serum (a gift of Yun-Bo Shi; #93338) was raised
against a multiple antigenic peptide corresponding to amino acids
104–123 of xTRβ. The antisera were tested at different dilutions to the
optimize the signal to noise ratio. The xTRα antiserum was found
to produce high background staining and to crossreact with xTRb
by Western blotting (X. laevis TR bacterial expression vectors
provided by Yun-Bo Shi) and thus was not used further (see
below). The xTRβ antiserum was used at a ﬁnal dilution of 1:4000
for IHC (discussed below).
Histochemistry
Tadpole heads were ﬁxed in 4% paraformaldehyde in 0.01 M
phosphate buffered saline (PBS) overnight at 4 °C. Brains were
removed from the skull and saturated with 30% sucrose in 0.01 M PBS
at 4 °C overnight, then embedded in Tissue-Tek Cryo-OCT compound
(Fisher Scientiﬁc) or M1 embedding matrix (Shandon Lipshaw, Inc.,
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either the sagittal of the transverse plane were made and stored at
−80 °C until processing for IHC or a combination of IHC and ISHH.
Immunostaining of mitotic cells
Newborn cells in the tadpole brain were detected by IHC for BrdU.
Brieﬂy, tissue sections were denatured with 2 N HCl at 37 °C for
30 min, rinsed with TBS and blocked with 5% normal goat serum in
TBS at room temperature (rt) for 15 min. Tissue sections were then
incubated with anti-BrdU serum (1:500; generated in rat; Serotec
Inc., NC) for 24 h at rt. We used anti-rat-FITC for ﬂuorescent detection
of primary anti-BrdU immune complexes.
Mitotic cells were detected using a rabbit antiserum raised against
human pH3 (Upstate Biotechnology, NY). The amino terminus of this
protein (serine 10) becomes phosphorylated during late G2 through
M phase of the cell cycle and has been used to detect dividing cells in
X. laevis (Saka and Smith, 2001; Schreiber et al., 2001). Brain sections
were ﬁrst incubated with the primary antibody at 1:500 overnight
at 4 °C. Primary immune complexes were detected using a
secondary antibody conjugated with Cy3 (1:500, Jackson ImmunoR-
esearch Laboratories, Inc., West Grove, PA). Sections were counter-
stained with a ﬂuorescent green nuclear stain (SYTO 13, Invitrogen,
Carlsbad, CA).
In situ hybridization for TR mRNAs, and combined ISHH for TRα with IHC
for BrdU
Linearized plasmid templates were prepared, and sense or
antisense digoxigenin (DIG)-labeled TR probes were transcribed in
vitro using a DIG RNA labeling kit (Boehringer-Mannheim). For ISHH,
cryosections were incubated with 1 μg of sense or antisense probe
overnight at 55 °C. Tissue preparation, hybridization and rinsing
followed standard protocols (Mansour et al., 1994). A monoclonal
mouse anti-DIG antibody (1:500; Roche) was used to detect RNA
hybrids. Primary immune complexes were detected with a goat anti-
mouse secondary antibody conjugated with Cy3. The speciﬁcities of
the riboprobes were conﬁrmed by the absence of signal with sense
probes on consecutive sections, and by the absence of signal with
antisense probes in premetamorphic tadpoles (for TRβ). For dual
ﬂuorescent immunodetection of TRα mRNA and BrdU brain sections
were ﬁrst processed for ISHH followed by IHC for BrdU as described
above.
Dual ﬂuorescent IHC for BrdU and TRβ protein
For double-labeling IHC, tadpole brain sections were ﬁrst
processed as described above for detection of BrdU. For detection
of TRβ protein, the slides were rinsed in TBS, blocked with
Superblock (Pierce Chemical Co.) plus 5% normal goat serum in TBS
for 15 min at rt, and incubated overnight at 4 °C with rabbit anti-TRβ
serum (1:4000). We used anti-rabbit-Cy3 for ﬂuorescent detection of
primary anti-TRβ immune complexes. Stained sections were ana-
lyzed by confocal microscopy using a Zeiss laser scanning confocal
microscope. Sections were scanned at 1 μm thickness using Z-stack to
determine if TRα mRNA and BrdU, or TRβ protein and BrdU were
colocalized.
To map TRβ immunoreactive (ir) cells throughout the tadpole
brain we treated NF stage 52 tadpoles with T3 (50 nM) for 48 h
before sacriﬁce. Brains were ﬁxed, cryosections prepared and
sections were stained with anti-TRβ serum (1:4000) as described
above, with the exception that we treated sections with 0.1% Triton
X-100 before blocking. For detecting primary immune complexes we
used the Vectastain elite ABC (rabbit) and Vector VIP kits (Vector
Laboratories, Inc., Burlingame, CA, USA) following the manufacturer's
instructions. We followed the anatomical deﬁnitions of Tuinhof et al.(1998) with modiﬁcation of basal ganglia subdivisions according to
Marín et al. (1998); see Yao et al. (2004).
Electroporation-mediated gene transfer
Brains of living premetamorphic tadpoles (NF stage 52) were
transfected with a X. laevis TRβ promoter-EGFP reporter plasmid (a
gift of Dr. Ken Oofusa; Oofusa et al., 2001) following methods
described by Haas et al. (2002) and Yao et al. (2007). This plasmid
contains the 5′ ﬂanking region of the X. laevis TrβA gene (−1562 to
+312) and has been used to generate transgenic animals by restriction
enzyme-mediated insertional transgenesis; these animals express
EGFP in a tissue-speciﬁc and T3-dependent manner (Oofusa et al.,
2001). Tadpoles were anesthetized in 0.002% benzocaine and given a
single intracerebroventricular (i.c.v.) injection of 92 nl DNA solution
(1 μg/μl; with 0.02% fastgreen dye) using a Drummond microinjector.
We then positioned a pair of platinum electrodes over the skull and
delivered ﬁve pulses of 30 V each. Tadpoles were allowed to recover
overnight, then treated with T3 (50 nM) for 48 h, and with BrdU
(500 μM) for 3 h before sacriﬁce and subsequent harvest of brains for
IHC. We conducted double labeling immunoﬂuorescence histochem-
istry and analyzed sections by confocal microscopy as described above.
We detected EGFP using a rabbit anti-GFP serum (1:5000; Torrey
Pines Biolabs, Houston, TX) and goat anti-rabbit Cy 3 secondary.
Data analysis and statistics
Image analysis was conducted in a blinded manner. All sections
were carefully matched for anatomical level, and digital micro-
graphic images of immunostained slides were captured using a
Nikon Eclipse E600 microscope (Nikon, Tokyo, Japan) and a Spot 10
CCD camera (Model 1.4.0; Diagnostic Instruments, Inc., Sterling
Heights, MI), or an Olympus IX81 inverted microscope (Olympus,
Tokyo, Japan) and a Retiga 1300R Fast digital video camera (QI
Imaging, Tuscon, AZ). Images were analyzed in a blinded manner
using Scion Image software (Scion Corp.) For BrdU, the total area of
BrdU-ir in discrete regions of the tadpole brain was determined,
and these values were compared by one-way ANOVA followed by a
post-hoc analysis using Fisher's LSD test (α=0.05). Cells staining
positive for pH3 were manually counted and differences between
treatments compared by one-way ANOVA. Data were log10
transformed prior to ANOVA if the variances were found to be
heterogeneous (Bartlett's test).
Results
T3 promotes cell proliferation in neurogenic zones of the early
prometamorphic tadpole brain by shortening the cell cycle
Treatment of premetamorphic tadpoles (NF stage 52) with T3
(50 nM for 48 h; BrdU present throughout) caused a large increase in
BrdU labeled cells in the VZ/SVZ throughout the tadpole brain
(Experiment 1; see Fig. 1 for experimental details; representative
sagittal sections are shown in Fig. 2A). The uptake of BrdU could be
affected by T3 treatment, so we used an independent method to
analyze cell proliferation. Immunohistochemistry for pH3 conﬁrmed
the proliferative actions of T3, revealing a 4-fold increase over controls
in the number of mitotic cells in the VZ/SVZ in brains of premeta-
morphic tadpoles treated with T3 for 48 h (Figs. 2B,C).
Using a ‘pulse–chase’ BrdU labeling protocol (Experiment 2; for
experimental details see Fig. 1) we found that the increased cell
proliferation in the VZ/SVZ caused by T3 was due to a shortening of the
cell cycle rather than the recruitment of more stem cells to proliferate.
At 24 h after addition of T3 there was no difference in BrdU labeling
between control vs. T3-treated tadpoles (Fig. 2D, panels 1, 2). However,
after 48 h of T3 treatment we observed a dramatic increase in the
Fig. 2. Thyroid hormone induces cell proliferation in the tadpole brain by shortening cell cycle time. (A) T3 induces cell proliferation in the premetamorphic tadpole (NF stage 52)
brain. Tadpoles were treated as described for Experiment 1 (see Fig. 1) and representative sagittal brain sections are shown stained for BrdU. Abbreviations: LV — lateral ventricle, IIIv—
third ventricle, tect— optic tectum, Cb— cerebellum. Scale bar=200 μm. (B) T3 increases cell proliferation as evidenced by an increased number of phosphorylated histone 3 (pH3) positive
cells. Tadpoles were treated as described for Experiment 1 and representative sagittal brain sections in the region of the optic tectum are shown stained for pH3. Scale bar=50 μm. (C)
Quantitation of the number of pH3 positive cells throughout the brain of tadpoles treated with or without T3 (50 nM) for 24 or 48 h (n=5/treatment). Transverse sections were prepared
and the number of pH3-positive nuclei were counted for each brain. The asterisk indicates statistically signiﬁcant difference from controls (Pb0.001; unpaired t-test). (D) T3 shortens cell
cycle time in early prometamorphic tadpole brain. Tadpoles were treated as described for Experiment 2. Transverse brain sections were stained for BrdU. There were no differences in
BrdU-ir between brains from control (panel 1) or T3 treated (panel 2) animals 24 h after treatment. However, after 48 h there was a signiﬁcant increase in the number of BrdU-ir cells in
brains of T3-treated animals (panel 4) compared to controls (panel 3). T3-treated animals exhibited more diffuse staining owing to the dilution of the BrdU by cell division. Many BrdU-ir
cells seen in panel 4 exhibited elongate nuclei, suggesting that the newborn cells were migrating out of the proliferative zone. Scale bar=50 μm.
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which exhibited more diffuse staining owing to the dilution of the
BrdU by cell division (Fig. 2D, panels 3,4). Many BrdU-ir cells exhibited
elongate nuclei, which suggests that these newborn cells were
migrating out of the proliferative zone. The diffuse staining pattern
of BrdU-ir in the brain following 48 h T3 treatment was not observed
in the pituitary gland, which showed intense BrdU staining that was
unaffected by T3 treatment (data not shown).
Developmental stage-dependent cell proliferation in the tadpole brain
We analyzed cell proliferation in the VZ/SVZ of the tadpole brain
during spontaneous metamorphosis or following T3 treatment at
different developmental stages (Fig. 3). During premetamorphosis
(NF stage 52–53) the rate of cell proliferation was low, rose slightly
between stages 52–53 and 54–55, then exhibited a dramatic increase
(∼4-fold) between stages 54–55 and 56–57 (prometamorphosis). The
rate of proliferation remained elevated during late prometamorpho-
sis (stage 58–59) and the beginning of metamorphic climax (stage
60–61) but dropped signiﬁcantly at the height of metamorphic
climax (stage 62–63).During premetamorphosis and early prometamorphosis the
numbers of proliferating cells were similar across different brain
regions (NF stages 52–55; Table 1). It is unlikely that the rate of cell
proliferation during this stage of development is entirely dependent
on endogenous thyroid hormone since mitosis proceeds in hypophy-
sectomized tadpoles (Race, 1961). Mitosis increased dramatically
thereafter, and the largest number of proliferating cells was observed
in the optic tectum at stage 56–57. The rate of proliferation in the
tectum dropped off precipitously thereafter; whereas, in other brain
regions the decline was slower and extended through metamorphic
climax (Table 1). Our analysis is in agreement with a description by
Filoni et al. (1995) in X. laevis tadpoles who reported that the most
dramatic decline in mitotic index through metamorphosis occurred in
the mesencephalon (containing the optic tectum); the decline was
slower in the cerebellum, and slowest in the telencephalon.
Treatment of tadpoles with T3 (50 nM) during premetamorphosis
and early prometamorphosis dramatically increased cell proliferation
in the VZ/SVZ throughout the brain, as measured by staining for both
pH3 and BrdU (Figs. 3A,B; data for pH3 not shown). By NF stage 56–57
when cell proliferation was maximal tadpoles became refractory to T3
treatment, which persisted through metamorphic climax. The decline
Fig. 3. (A) Proﬁles of brain cell proliferation during spontaneous metamorphosis and
following T3 treatment, measured by the number of BrdU-positive cells. Tadpoles were
treated as described for Experiment 3 (see Fig. 1). During spontaneous metamorphosis
(Control) cell proliferation was low at premetamorphic (Premet) stages, peaked during
prometamorphosis (Promet; NF stage 56–57) and declined at metamorphic climax
(Climax; NF stage 62–63). T3 treatment signiﬁcantly increased cell proliferation at
premetamorphic and early prometamorphic stages but failed to alter cell proliferation at
later stages. (B) Developmental changes in BrdU labeling in the tadpole optic tectum.
There were numerous BrdU-ir cells at prometamorphosis (NF stage 56; b); whereas, there
were few BrdU-ir cells in premetamorphic (NF stage 52; a) or late prometamorphic (NF
stage 62; c) brains. tect, optic tectum; V, ventricle. Scale bar=50 μm.
Fig. 4. Blockade of endogenous thyroid hormone synthesis by the goitrogen
methimazole reduces cell proliferation in tadpole brain. Tadpoles were treated as
described for Experiment 4 (see Fig. 1). Prometamorphic tadpoles (NF stage 56) were
treated with or without methimazole (MMI; 1 mM) for 1 week. A subset of animals
received T3 (10 nM) for the ﬁnal 2 days of the treatment period. MMI treatment reduced
brain cell proliferation, as measured by pH3 staining. Addition of exogenous T3 to the
MMI-treated tadpoles restored the rate of proliferation to a level comparable to that of
controls.
160 R.J. Denver et al. / Developmental Biology 326 (2009) 155–168in cell proliferation at metamorphic climax (NF stage 62–63) could not
be rescued by T3 treatment.
To test whether the high rate of cell proliferation during
prometamorphosis depends on endogenous thyroid hormone we
treated NF stage 56 tadpoles with the goitrogen MMI (Experiment 4;
see Fig 1 for details). MMI treatment caused a signiﬁcant decrease in
the number of BrdU positive cells throughout the tadpole brain, which
was rescued by treatment with T3 (Fig. 4).Table 1
Relative numbers of BrdU-ir or pH3-ir cells throughout the X. laevis tadpole brain
during metamorphosis
Telencephalon Diencephalon Tectum Cerebellum
Stage 52–53 + + + +
Stage 54–55 + + + +
Stage 56–57 +++ +++ +++ +++
Stage 58–59 ++ ++ ++ ++
Stage 60–61 ++ + − +
Stage 62–63 + + − −
Tadpoles were treated with BrdU as described for Experiment 3 (see Fig. 1).
Immunohistochemistry was conducted for BrdU or pH3 as described in Materials and
methods. Developmental staging is Nieuwkoop and Faber (Nieuwkoop and Faber,1994).
The plus signs indicate relative numbers of BrdU or pH3 positive cells observed
throughout the tadpole brain compared to the maximum level seen in the optic tectum
at stage 56–57. The minus signs indicate no BrdU or pH3 positive cells were observed.Distribution of TRα and TRβ, and location of neurogenic zones in the
tadpole brain
Neurogenic zones, as identiﬁed based on the distribution of
BrDU-ir and pH3-ir, occur in all periventricular regions throughout
the tadpole brain as indicated in Fig. 5 (see also Schreiber et al.,
2001; Wullimann et al., 2005). In situ hybridization histochemistry
for TRα mRNA showed that this transcript is widely and highly
expressed in the tadpole brain as has been reported previously
(Kawahara et al., 1991). TRα mRNA was expressed in virtually all
cells in the brain, and we found no signiﬁcant effect of T3 treatment
on TRα expression, nor did we observe any signal on sections
hybridized with sense probe (data not shown). We were unable to
conduct IHC for TRα as the currently available antisera for Xenopus
TRα exhibited high nonspeciﬁc activity and crossreaction with TRβ
(see Fig. 6A).
We detected expression of TRβ mRNA in the tadpole brain only
after treatment with T3, but the signal was too low to accurately
document. This is consistent with the very low TRβ signal (compared
to TRα) reported by Kawahara et al. (1991) in X. laevis tadpole brain.
By contrast, while TRβ immunoreactivity (TRβ-ir; analyzed by IHC) in
premetamorphic tadpole brain was low, it increased dramatically
following T3 treatment which allowed us to map its expression
throughout the tadpole brain (Figs. 5, 6B). We observed discrete
groups of TRβ-ir cells in the telencephalon, diencephalon, mesence-
phalon, and rhombencephalon. The TRβ-ir was restricted to the cell
nuclei, and occurred predominantly outside of the neurogenic zones
lining the ventricles (see Fig. 6B). A schematic representation of the
distribution of TRβ-ir cells in the tadpole brain and pituitary gland is
shown in Fig. 5 and representative immunostained sections are shown
in Fig. 6B.
In the telencephalon (Fig. 5, panels A–C), the most rostral sites of
TRβ-ir were seen in the lateral pallium within the olfactory bulbs. In
the caudal telencephalon, strongly stained TRβ-ir cells were localized
in the dorsal, lateral and medial pallium, striatum, lateral septum
and nucleus accumbens (see Fig. 6B, panels 1,2). In the rostral
telencephalon (Fig. 5, panels D–H) TRβ-ir cells were observed in the
lateral, medial, and central amygdala (see Fig. 6B, panel 3). TRβ-ir
cells were localized in both the parvocellular (Fig. 6B, panel 4) and
the magnocellular divisions of the anterior preoptic area (site of
hypophysiotropic neurosecretory neurons in the frog brain), and in
the diencephalon, in the hypothalamus (Fig. 6B, panel 5) thalamus,
Fig. 5. (A–L) Schematic coronal illustration of neurogenic zones (gray bands surrounding ventricles on left of sections; identiﬁed by the distribution of BrDU and pH3
immunoreactivity) and thyroid hormone receptor β (TRβ) immunoreactivity (-ir; large and small dots on right of sections) distribution in the brain of NF stage 52 X. laevis tadpoles
following 48 h treatment with T3 (50 nM). TRα mRNA, which is not shown in the ﬁgure, is highly expressed in all neurogenic zones and many other areas throughout the tadpole
brain. The drawing at the top of the ﬁgure shows a dorsal view of the X. laevis brain. Letters correspond to the rostrocaudal location of sections as depicted in thewhole-brain drawing.
Large circles represent large cells that exhibited robust TRβ-ir, and small circles represent smaller TRβ-ir cells. The anatomical drawings are from Tuinhof et al. (1998), with
modiﬁcations of basal ganglia subdivisions according to (Marín et al., 1998). Abbreviations are deﬁned in Table 2.
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Table 2
Abbreviations
A Anterior thalamic nucleus
Acc Nucleus accumbens
BNST Bed nucleus of the stria terminalis
Cb Cerebellum
CeA Central amygdala
dp Dorsal pallium
Hd Dorsal habenular nucleus
Hv Ventral habenular nucleus
IIIv Third ventricle
igl Internal granule cell layer
L Lateral thalamic nucleus
LA Lateral amygdala
lp Lateral pallium
LPv Lateral thalamic nucleus
ls Lateral septum
lv Lateral ventricle
ME Median eminence
MeA Medial amygdala
ml Mitral layer
mp Medial pallium
ms Medial septum
nII Cranial nerve II
P Posterior thalamic nucleus
pd Pars distalis
pi Pars intermedia
pn Pars nervosa
POa Preoptic area
Ra Raphe nucleus
Rm Nucleus reticularis medius
SC Suprachiasmatic nucleus
Str Striatum
tect Optic tectum
tegm Mesencephalic tectum
Tn Tegmental nuclei
TP Posterior tuberculum
VH Ventral hypothalamic nucleus
VLs Superﬁcial ventral nucleus
VM Ventromedial thalamic nucleus
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mesencephalon (Fig. 5, panels I–J) we observed strong TRβ-ir cells in
different layers of the optic tectum (Fig. 6B, panel 6), the torus
semicircularis, and tegmental nuclei. In the rhombencephalon (Fig. 5,
panels K–L) TRβ-ir was observed in the cerebellum, and small,
weakly stained TRβ-ir cells were seen in the raphe nuclei, reticular
nuclei, and nuclei of the trigeminal motor nerves. In the pituitary
gland strong TRβ-ir was found distributed throughout the pars
distalis and the pars intermedia.
TRα but not TRβ is expressed in proliferating cells in the tadpole brain
Dual labeling for TRα mRNA and BrdU revealed that all BrdU-ir
cells express TRα (Fig. 7A; only the hypothalamus and cerebellum are
shown, and identical results were obtained in other brain areas). The
T3 treatment/BrdU labeling protocol used was that described for
Experiment 3 (see Fig. 1 for details) where BrdU was given for a brief,
3 h period at the end of 48 h of T3 treatment. Therefore, cells that are
actively proliferating express TRα mRNA. The strongest staining for
TRα mRNA was seen in BrdU-positive cells, but not all cells that
expressed TRα mRNA were BrdU positive.
Using double immunoﬂuorescence labeling and confocal micro-
scopy we found that the majority of BrdU-ir cells were negative for
TRβ protein (Fig. 7B; representative sagittal sections through the
region of the thalamus and optic tectum are shown, and identical
results were obtained in other brain areas; protocol Experiment 3;
see Fig. 1). The TRβ-ir was seen predominantly outside of the VZ/SVZ
(see also Fig. 6B), and while we observed some TRβ-ir in parts of the
VZ/SVZ, these areas were not undergoing active neurogenesis in
response to T3.Transfection of tadpole brain in vivo with a TRβ promoter-EGFP plasmid
showed that the majority of EGFP expressing cells were not dividing
To corroborate the TRβ expression pattern that we observed by
IHC, we used electroporation-mediated gene transfer to transfect the
brains of living premetamorphic tadpoles with a vector containing the
frog proximal TrβA promoter driving EGFP (Oofusa et al., 2001).
Plasmid DNA was injected into the region of the third ventricle and
electrical current was applied. EGFP ﬂuorescence was very low in
untreated tadpole brain but was increased strongly by treatment with
T3 as has been reported previously (Oofusa et al., 2001). Similarly, the
rate of cell proliferation as assessed by BrdU labeling was low in
untreated tadpole brain; therefore, only brain sections from tadpoles
treated with T3 were analyzed by confocal microscopy and are shown
in Fig. 8. We observed 94% of EGFP expressing cells at the periphery or
within the SVZ. We found a few EGFP-positive cells more distal to the
SVZ, which was limited by the transfection efﬁciency as the distance
from the ventricular surface increased. Only 6% of EGFP positive cells
were seen within the VZ (n=12; Fig. 8, panels 1, 2). Confocal
microscopy conﬁrmed that the majority of EGFP expressing cells
(74%) were not labeled with BrdU, and these cells possessed short or
no visible processes (Fig. 8, panels 1, 2). Of the cells in which EGFP and
BrdU were colocalized (26%) most had the morphology of radial glia,
with long processes that terminated in endfeet at the pial and
ventricular surfaces (Fig. 8, panels 3, 4).
TRα-selective, but not TRβ-selective ligands induce cell proliferation in
the tadpole brain
As we found earlier, treatment with T3 for 48 h caused a large
increase in cell proliferation in the VZ/SVZ throughout the tadpole
brain. However, the TRβ selective ligands GC1 or GC24 did not alter
brain cell proliferation, while the TRα selective ligand CO23 increased
brain cell proliferation similar to the T3 treated group (F(4,15)=6.734,
P=0.003; ANOVA; Fig. 9A). We conﬁrmed the potencies of the GC
analogs in vivo by treating tadpoles for 6 days with GC1 or GC24 and
observed morphological changes similar to those reported previously
by Furlow et al. (2004); GC1 and GC24 caused the digits to
differentiate and the gills to resorb; Fig. 9B).
Discussion
Cell proliferation in ventricular and subventricular zones through-
out the tadpole brain increased dramatically as the animals entered
metamorphosis, which correlates with the rise in plasma T3
concentration at this time. Mitosis can be induced precociously by
the addition of T3 to the aquariumwater of premetamorphic tadpoles.
Conversely, cell proliferation in the prometamorphic tadpole brain
was reduced to premetamorphic levels by blocking the endogenous
rise in plasma T3. We provide evidence that the action of T3 on
neurogenesis is mediated by the alpha subtype of the thyroid
hormone receptor, and may be cell autonomous. We found TRα to
be highly expressed in the VZ/SVZ of the X. laevis tadpole brain,
regions of active neurogenesis; whereas, TRβ was expressed
predominantly outside of neurogenic zones where cells undergo
migration and differentiation. The induction of brain cell prolifera-
tion by the TRα selective agonist CO23, but the failure of TRβ
selective ligands to induce cell proliferation at concentrations that
preferentially activate TRβ support the view that the TRα mediates
the hormone response.
Patterns and rates of cell proliferation in the tadpole brain
Earlier studies of mitosis in the tadpole nervous system, and the
effects of exogenous thyroid hormone were summarized by Jacobson
(1991). In agreement with these studies, we found that mitotic activity
Fig. 6. (A) Western blots testing the speciﬁcity of antisera raised against synthetic peptides corresponding to xTRα (top gel; 1:1000) and xTRβ (bottom gel; 1:1000). Polyacrylamide
gels (10 %) were loaded with lysates of bacteria expressing xTRα (lanes 1,2,3: 5, 2.5, 1.25 μl induced lysate; lane 4, 5 μl uninduced lysate) or xTRβ (lanes 5,6,7: 5, 2.5, 1.25 μl induced
lysate; lane 8, 5 μl uninduced lysate). Note that the anti-xTRα serum crossreacts with xTRβ (arrows showing two immunoreactive bands in both lysates) and was not used for further
study; whereas, the anti-xTRβ serum was speciﬁc for xTRβ and was used for IHC. (B) Representative photomicrographs of transverse sections through the brain of a NF stage 52
tadpole that had been treated with T3 (50 nM) for 48 h showing the distribution of TRβ immunoreactive (TRβ-ir) cells. 1. Dorsal pallium (dp), medial pallium (mp) and lateral pallium
(lp), and internal granule cell layer (igl; Fig. 5, panel B). 2. Dorsal, medial and lateral pallium, striatum (Str) and accumbens (Acc; Fig. 5, panel C). 3. Dorsal, medial and lateral pallium,
lateral amygdala (LA), medial amygdala (MeA) and central amygdala (CeA; Fig. 5, panel D). 4. Anterior preoptic area (Fig. 5, panel D). 5. Ventral hypothalamic area (Fig. 5, panel G). 6.
Optic tectum (Fig. 5, panel J). Scale bar=200 μm.
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activity increased dramatically during early prometamorphosis, which
is coincident with the rise in endogenous thyroid hormone production
(Krain and Denver, 2004; Leloup and Buscaglia, 1977; Tata, 1993). The
mitotic activity reached a peak at mid-prometamorphosis, then
declined through late-prometamorphosis and climax. We observed
brain regional differences in the magnitude of mitotic activity at the
peak (NF stage 56–57), with the optic tectum exhibiting the highest
mitotic index. Cell proliferation in the optic tectum dropped off
precipitously by stage 58 and was absent thereafter; whereas, cell
proliferation continued in the telencephalon, diencephalon and
cerebellum through metamorphic climax (see Table 1, Fig. 3).
The rate of cell proliferation in the early prometamorphic tadpole
brain was low, but could be increased dramatically by treatment with
exogenous T3. We also found that treatment with the goitrogen MMI
decreased mitosis in prometamorphic animals to levels seen in the
premetamorphic tadpole brain, and that this could be reversed by T3
treatment. These ﬁndings show that the increase in the rate of cellproliferation that occurs during prometamorphosis depends upon the
endogenous rise in thyroid hormone production. Reynolds (1966)
reported that treatment with thiourea decreased cell proliferation in
the lumbosacral spinal cord of Rana pipiens tadpoles. However,
Reynolds did not conduct a rescue/replacement experiment to rule
out the possibility of a nonspeciﬁc, or neurotoxic effect of the
chemical. Here we show that the decrease caused by the goitrogen
could be rescued by replacement with T3.
Our ‘pulse–chase’ experiment showed that T3 stimulated cell
proliferation by shortening cell cycling time rather than by recruiting
more stem cells to proliferate. This is consistent with ﬁndings in rat
pituitary GH producing GC cells which proliferate in response to T3
by shortening G1 phase (Barrera-Hernandez et al., 1999). These
investigators also showed that T3 increased expression of cyclins D1
and E, and cdk2, and increased phosphorylation of retinoblastoma
protein which is responsible for driving G1 to S cell cycle progression.
The increased mitosis with exogenous thyroid hormone does not
appear to lead to an increase in the ﬁnal size of the tadpole brain
Fig. 7. (A) Thyroid hormone receptor alpha (TRα) mRNA colocalizes with BrdU-ir in tadpole brain. Premetamorphic (NF stage 52) tadpoles were treated as described for Experiment 3
(see Fig. 1). Dual labeling histochemistry was conducted for TRαmRNA (red; by ISHH) and BrdU (green; by IHC) on sagittal sections of T3-treated tadpole brain (regions shown are the
diencephalon and cerebellum). Sections were analyzed by confocal microscopy. Note the colocalization of TRα mRNA and BrdU-ir in cords of cells adjacent to the ventricles. Hypo,
hypothalamus; Pit, pituitary. Scale bar=50 μm. (B) Treatment with T3 increases TRβ immunoreactivity (ir) in tadpole brain, and TRβ is excluded from the majority of BrdU-positive
cells. Premetamorphic tadpoles (NF stage 52) were treated as described for Experiment 3 (see Fig. 1). Dual ﬂuorescent immunohistochemistry was conducted for BrdU (green) and
TRβ (red) without (1–3) or with (4–6) T3 treatment. Sections were analyzed by confocal microscopy. Shown is the region of the thalamus and optic tectum in the sagittal plane. In
untreated tadpoles few BrdU-ir or TR-ir cells are detected (1— TRβ, 2— BrdU, 3—merge), but T3 treatment signiﬁcantly increased TRβ-ir (4— TRβ) and cell proliferation (5— BrdU).
Only a small proportion of BrdU-ir cells express TRβ, as indicated by the yellow cells (6 — merge). Scale bar=50 μm.
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achieve normal brain size in amphibians. For example, although
thyroidectomized tadpoles reach a giant body size their brains are
smaller than controls (Allen, 1924). A similar situation is seen in the
rat (reviewed by Anderson et al., 2003). By NF stage 56–57 when the
spontaneous rate of cell proliferation is highest, tadpoles become
refractory to exogenous T3. This suggests that while exogenous
thyroid hormone can induce precocious cell proliferation, it does not
lead to the production of more cells; i.e., there is a ﬁnite precursor
pool with a ﬁnite number of possible cell divisions.
We found that exogenous T3 could not rescue the decline in
proliferation that occurs at metamorphic climax. Cai and Brown
(2004) proposed that the expression of deiodinase type II (D2),
which converts T4 to T3, is necessary for the actions of T4 on brain
cell proliferation, and the decline in D2 expression in the tadpole
VZ/SVZ may be causally related to the cessation of cell proliferation
in the tadpole brain. However, this implies that while the cells may
not respond to T4, they should still be responsive to T3, but they
are not. Earlier we showed that a 50 nM dose of T3 produces tissue
concentrations of ∼480 nM by 24 h of treatment (i.e. the hormone
is actively taken up and concentrated from the medium), whichcontrasts with a peak of ∼18 nM T3 tissue concentration at
metamorphic climax (Krain and Denver, 2004). If the cells could
respond to T3 by proliferating, then the dose of hormone should
have been more than sufﬁcient. Therefore, the decrease in D2 may
be correlated with a terminal differentiation event, but it is
probably not responsible for the lack of thyroid hormone action on
brain cell proliferation in late prometamorphic and climax stage
tadpoles.
Expression and roles of TR subtypes in neurogenesis in the tadpole brain
Several investigators have analyzed the expression of TRs in
tadpoles during metamorphosis. In X. laevis TRα expression increases
shortly after hatching and is maintained at a high level throughout
metamorphosis, declining after climax (reviewed by Shi, 2000). TRα
transcripts are detectable in all tadpole cells that have been examined,
and the highest expression is seen in cells that proliferate upon
treatment with T3; e.g, the limb buds, basal layers of the skin, speciﬁc
head cartilages and SZ/SVZ zones of the brain (Berry et al., 1998a).
During early prometamorphosis when plasma thyroid hormone
concentrations are low but starting to rise, cell proliferation increases
Fig. 8. Distinct populations of cells respond to T3 by proliferating (as evidenced by BrdU incorporation — green) or by upregulating the TrβA promoter (as evidenced by EGFP
expression— red). Premetamorphic tadpoles (NF stage 52) were transfected with a X. laevis TrβA promoter-EGFP reporter plasmid by electroporation-mediated gene transfer, treated
with T3 (50 nM) for 48 h, and then immersed in BrdU for 3 h before sacriﬁce and harvest of brains for dual labeling ﬂuorescent immunohistochemistry for EGFP and BrdU. Transverse
sections through the lateral ventricles were prepared and analyzed by confocal microscopy. 1. A majority of EGFP-positive cells (red — with white arrows) were BrdU negative. The
yellow arrow shows one cell with colocalization of EGFP and BrdU. Scale bar=100 μm. 2. High magniﬁcation image showing that most EGFP-positive cells are located at the periphery
of the subventricular zone (SVZ), with few in the ventricular zone (VZ). Scale bar=50 μm. 3. Some EGFP expressing cells exhibited long processes that extended out to the pial surface
characteristic of radial glia. Scale bar=200 μm. 4. Most radial glial cells expressing EGFP were BrdU positive (yellow arrows) with cell bodies located in the SVZ. Scale bar=50 μm.
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and both have high constitutive levels of TRα mRNA (see Fig. 7A;
Furlow and Neff, 2006; Schreiber et al., 2001). By contrast, TRβ
mRNA expression is low or nondetectable during embryogenesis
and premetamorphosis, but then is strongly induced during
prometamorphosis coincident with rising plasma T3 concentrations
(Krain and Denver, 2004; Yaoita and Brown, 1990). During
prometamorphosis TRβ is highly expressed in resorbing tissues
such as the tail, and in the brain, which at this time undergoes
extensive cell migration and neuronal differentiation/maturation
(Denver, 1998), but at relatively low levels in most proliferating
tissues (Berry et al., 1998a; Furlow and Neff, 2006). TRβ mRNA
expression peaks at metamorphic climax (NF stage 60; Krain and
Denver, 2004; Yaoita and Brown, 1990) when the rate of cell
proliferation is declining (see Fig. 3). Levels of TRα protein were
estimated to be 2–3 times greater than TRβ in the head and tail of
premetamorphic tadpoles and did not change signiﬁcantly through-
out metamorphosis, while TRβ protein increased strongly through
metamorphic climax (Eliceiri and Brown, 1994). These expression
patterns, and other lines of evidence have led to the hypothesis that
the two TR subtypes serve different developmental roles. The early
expression of TRα establishes tissue competence to respond to T3,
thus supporting the early proliferative actions of the hormone
(Furlow and Neff, 2006; Tata, 2006), and prior to the production of
T3, the aporeceptor may repress gene expression (dual-function
model; see Buchholz et al., 2006). Whereas, the upregulation of TRβ
in response to T3 functions in tissue remodeling and organogenesis
through regulation of apoptosis and cell differentiation (Furlow and
Neff, 2006; Tata, 2006).Kawahara et al. (1991) conducted a rough analysis of TRα and
TRβ mRNA expression in the tadpole by ISHH and reported that
TRα was widely and highly expressed compared with TRβ, which
was only induced by T3 at metamorphosis and exhibited a
restricted expression pattern within tissues. Using ISHH we also
found TRα expression throughout the tadpole brain, which is
consistent with widespread expression of TRα transcripts (TRα1
and TRα2) in mammalian brain (Bradley et al., 1992). Similar, to the
ﬁndings of Kawahara et al. (1991) we found that TRβ expression in
premetamorphic tadpole brain was very low, but increased
dramatically in several brain areas following treatment with T3.
We found strongest TRβ-ir outside of neurogenic zones in the
tadpole brain (see Fig. 6B). Furthermore, EGFP expression driven by
the xTRβ promoter in transfected tadpole brain was observed
predominantly in cells that were not proliferating. The TRβ
expression pattern, as evidenced by two independent methods, is
consistent with a lack of involvement of TRβ in brain cell
proliferation. While the majority of TRβ-ir was outside of the VZ/
SVZ, there was some TRβ staining in parts of the VZ/SVZ that were
not undergoing active neurogenesis following treatment with T3.
Berry et al. (1998b) reported both TRα and TRβ mRNA expression
by ISHH in the ventricular region of the tail spinal cord but did not
analyze their expression speciﬁcally in mitotic cells.
We observed strong expression of EGFP driven by the xTRβ
promoter in radial glia, which extended long processes from the
SVZ to the pial and ventricular surfaces, and most of these cells
were also BrdU positive. During mitosis the long processes of
radial glia cells remain attached to the pial and ventricular
surfaces (Miyata et al., 2001; Noctor et al., 2001). These cells
Fig. 9. The TRα selective agonist CO23, but not the TRβ selective agonists GC1 and GC24,
increases cell proliferation in the premetamorphic tadpole brain. (A) Quantiﬁcation of
the number of pH3-positive nuclei in the region of the lateral ventricles in tadpoles
treated with vehicle (DMSO; control), T3 (10 nM), GC1 (100 nM), GC24 (100 nM) or CO23
(100 nM) for 48 h. Compounds were added to the aquariumwater and were replenished
after 24 h. The length of both lateral ventricles from each animal was analyzed. Shown
are the data from one of two experiments that gave identical results. (Pb0.05; ANOVA;
n=4/treatment). (B) The GC compounds caused external metamorphic changes, thus
showing that they had biological activity. Shown are representative tadpoles treated
with vehicle (DMSO; control), GC1 or GC24 (100 nM each) for 6 days (all of the T3
treated tadpoles had died by 4 days and thus are not shown; CO23 animals were not
analyzed — the effects on brain cell proliferation veriﬁed the biological activity of the
CO23). The arrows point to the gills, which showed resorption following treatment with
GC1 and GC24. Differentiation of the hindlimb digits was observed with both GC1 and
GC24 treatment but not in controls (n=6/treatment).
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and post-mitotic neuronal daughter cells with each round of cell
division (Götz and Huttner, 2005). The strong EGFP expression in
these cells driven by the xTRβ promoter is consistent with TRβ
being expressed in cells that display a differentiated phenotype
(i.e., long processes). It also suggests that, while TRβ may not
promote cell proliferation, it also may not antagonize entry into or
progression through the cell cycle (contrary to what has been
found in the mouse neuronal cell line Neuro-2a; Lebel et al., 1994).
It is possible that the expression of TRβ turns off as the radial glial
cells progress through the cell cycle. In our experiments the
tadpoles were pulsed with BrdU 3 h before sacriﬁce, and so all of
the BrdU-labeled nuclei represented cells that were born within
that 3 h period. It would be interesting to examine whether in the
following hours, as the cell progresses through the cell cycle, the
TRβ promoter is turned off and then on again in the radial glial
cell, and on in the post-mitotic neuronal daughter cell.
The induction of cell proliferation by the TRα-selective agonist
CO23, but the failure of the TRβ selective agonists GC1 and GC24
to affect proliferation is consistent with the TRα mediating
proliferative actions of T3. Evidence for the TRα selectivity of
CO23 in X. laevis in vivo is supported by the ﬁnding that it causedsigniﬁcant hindlimb growth with roughly equal potency to T3, but
was much less potent in affecting tail and gill resorption, or cranial
restructuring (Ocasio and Scanlan, 2006). Growth of the hindlimbs
is one of the earliest observable thyroid hormone-dependent
changes and is thought to be dependent on TRα since this
receptor subtype is highly expressed in this tissue, while the
expression of TRβ is low and restricted to the area of the digits
(Buckbinder and Brown, 1992; Fairclough and Tata, 1997); whereas,
tissue resorption and differentiation (including the digits of the
limbs) occurs later upon autoinduction of TRβ (Furlow and Neff,
2006). While we did not analyze speciﬁc roles for TRβ in the
current study, it is noteworthy that the TRβ-speciﬁc analogs
caused differentiation of the hindlimb digits and gill resorption,
but not cell proliferation in the brain. In both amphibians and
mammals the expression of TRβ correlates closely with T3-
dependent morphogenesis (Furlow and Neff, 2006; Nunez et al.,
2008), and ﬁndings support the hypothesis that TRβ controls cell
differentiation and apoptosis but not neural cell proliferation (Lebel
et al., 1994; Perez-Juste and Aranda, 1999). Although GC1 binds
preferentially to TRβ, it can also interact with TRα, albeit with
4–10-fold lower afﬁnity (Baxter et al., 2004; Chiellini et al., 1998).
By contrast, GC24 had 10-fold greater selectivity for TRβ vs. TRα
compared with GC1 based on binding afﬁnity, and thus is a more
selective ligand for TRβ (Borngraeber et al., 2003). Further support
for TRα mediating cell proliferation, and TRβ mediating tissue
resorption and cell differentiation, was provided by sequential
treatment of tadpoles with CO23 then GC1, or GC1 then CO23
(Ocasio and Scanlan, 2006).
Findings from other laboratories support the view that TRα
mediates the proliferative actions of T3 on neuroblasts. For example,
Lezoualch et al. (1995) transfected embryonic chick optic lobe with
antisense oligonucleotides (ODNs) directed against TRα and found a
signiﬁcant decrease in [3H]thymidine incorporation; whereas, anti-
sense ODNs to TRβ had no effect. The efﬁcacy of the knockdown of
both TRα and TRβ by the respective antisense ODNs was conﬁrmed
by the loss of T3-activated reporter activity in transfected tissues.
Lemkine et al. (2005) concluded that liganded TRα is essential for
neurogenesis in adult mammal brain. They showed, using TR subtype
speciﬁc knockout mice, that TRα but not TRβ is essential for T3-
dependent adult neural stem cell proliferation. Morte et al. (2002)
found that, by contrast to the effects of T3, treatment with the TRβ-
speciﬁc analog GC1 did not promote cerebellar granule cell migration
but partially enhanced Purkinje cell maturation in mouse. Taken
together with their analysis of the TRα1 knockout mouse, they
concluded that granule cell migration (and perhaps proliferation) is
under the control of TRα1, while Purkinje cell maturation may be
mediated by TRβ (see also Hashimoto et al., 2001). Schlosser et al.
(2002) found an increase in the number of xNeuroD positive cells
(i.e., neurons) in the spinal cord of early stage Xenopus tadpoles with
T3 (NF stage 35/36), a stage at which TRα, but not TRβ is expressed.
They also showed that injecting mRNAs for xTRα plus RXR into Xe-
nopus embryos increased neurogenic responses to T3 in the spinal
cord, but repressed neurogenesis in the absence of hormone. Other
cell types have been shown to require TRα for proliferation in mouse
(e.g., Sertoli cells: Holsberger et al., 2005; erythroblasts: Angelin-
Duclos et al., 2005).
In summary, our ﬁndings show that the increase in proliferation in
the tadpole brain during metamorphosis depends on the rise in
endogenous T3 production. The magnitude of mitotic activity varies
with brain region, being highest in the optic tectum, where it drops off
precipitously after stage 58, but continues in other brain areas through
metamorphic climax. Expression analysis of TRα and TRβ, and studies
with TRα and TRβ selective ligands support the hypothesis that the
action of thyroid hormone on neurogenesis in the tadpole brain may
be cell autonomous, and is mediated by the alpha subtype of the
thyroid hormone receptor.
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